Peptide ProvidersDirect

Trust center

Privacy notice

A data-minimizing launch draft describing what the directory collects and deliberately avoids.

Launch draft: This document is an operational placeholder and must be reviewed by qualified counsel before real-provider publication.

Information collected

The MVP may collect account identity for protected workflows, business contact details, provider submissions, public source URLs, correction requests, security logs, and privacy-safe product analytics.

  • No medical histories, diagnoses, symptoms, medications, dosage requests, lab results, or medical documents.
  • No sensitive form values are sent to analytics.
  • Administrative access is logged.

Purpose and retention

Information is used to operate, secure, moderate, and improve the directory. A production retention schedule will define deletion windows by record type, legal need, and security purpose.

Rights and contact

A verified privacy-request channel, applicable regional disclosures, subprocessors, cookie choices, and deletion procedures must be finalized before launch.

Last operational review: July 15, 2026. Contact information will be added before public launch.